Please login to the form below

deafness

This page shows the latest deafness news and features for those working in and with pharma, biotech and healthcare.

and a host of other complications including blindness, deafness, learning disabilities and pain.

BioMarin's real world data sways NICE on orphan drug Vimizim

heart disease, dental and eye care, pain relief, and hearing aids and ventilating tubes to manage deafness and middle ear effusions.
Hearing loss prevention drugs expected by 2020

Report by Action on Hearing Loss launched today
NICE backs Roche's MabThera in rare autoimmune disease

indication, with ANCA-associated vasculitis an umbrella term for several related conditions that usually affect the lungs, kidneys, ears, nose or sinuses, sometimes leading to organ damage, bleeding or deafness.
Novartis wins childhood arthritis indication for Ilaris in EU

The approval adds to Ilaris' existing approvals in the EU to treat the rare inflammatory disorder cryopyrin-associated periodic syndromes (CAPS), which can lead to deafness and loss of vision, and
European approval for GSK’s meningitis vaccine Nimenrix

The form of meningitis it protects against has the potent to cause deafness, epilepsy and other neurological disordere, and it its most serious incidents can results in death.

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Significant figures

The liposome technology creates a shield that keeps most of the drug out of direct contact with a patient’s blood, successfully dodging Amikacin’s severe side effects, which include deafness,
The impending threat of antibiotic resistance

Pneumonia. 1 in 3 people died. Ear infection. Caused deafness. Surgery.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Home based, Principal Medical Writer, Medical Communications: Excellent package

Home based, Senior Medical Writer, Medical Communications: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Home based, Editorial Team Leader, Medical Communications: Excellent package

Add my company

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....